Skip to main content
Premium Trial:

Request an Annual Quote

Millipore Teams with Agilent to Develop ChIP Kits for Epigenetics

NEW YORK (GenomeWeb News) – Millipore said today that it will work with Agilent Technologies to develop chromatin immunoprecipitation kits for the epigenetics research market.
 
The collaboration will involve teaming Millipore’s knowledge in ChIP kits, reagents, and antibodies with Agilent’s microarray and data analysis solutions, the Billerica, Mass.-based Millipore stated.
 
The aim is to use these combined technologies to create kits that will improve researchers’ productivity and streamline genetic analysis studies, the companies said.
 
“We expect to help epigenetics researchers minimize the barriers of entry into chromatin state mapping, readily obtain reproducible genomic profiling data, and overcome the traditional challenges of ChIP assays," said Geoffrey Crouse, VP of Millipore's life science strategic business unit.
 
Agilent developed its microarray-based ChIP-on-chip technology after its 2005 acquisition of Computational Biology Corporation.
 

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.